Revance Therapeutics shares owned by Linden Advisors
Quarter-by-quarter ownership of Revance Therapeutics shares owned by Linden Advisors
from 13F filings
Historical chart of Linden Advisors investment in Revance Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Revance Therapeutics held by Linden Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Revance Therapeutics by Linden Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-09-30 | $7.2B | 9.0M | 804.74 |
| 2023-06-30 | $19B | 18M | 1056.43 |
| 2023-03-31 | $25M | 20M | 1.23 |